Core Viewpoint - The company is expanding its production capacity for biopharmaceutical separation and purification media to meet the growing demand in the pharmaceutical industry, with significant investments in its facilities in Yangzhou [1] Group 1: Production Capacity - The company has a large-scale production base in Yangzhou covering an area of 41,405 square meters [1] - Current production capacity for biopharmaceutical chromatography media is 24,760 liters [1] - The company is constructing a second phase of the Yangzhou project, expected to be completed by the end of 2026, which will increase total production capacity to 224,760 liters annually [1] Group 2: Market Demand - The expansion is aimed at addressing the rapid growth in the downstream pharmaceutical industry's demand for separation and purification solutions [1] - The increased production capacity will provide a solid foundation for the company's business expansion in the biopharmaceutical sector [1]
赛分科技：公司在扬州建有占地41405平方米的大规模生产基地